Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04862663
Brief Title: Capivasertib + Palbociclib + Fulvestrant for HR+/HER2- Advanced Breast Cancer (CAPItello-292). (CAPItello-292)

First Submitted : March 17, 2021
First Submitted that Met QC Criteria : April 23, 2021
First Posted : April 28, 2021

Last Update Submitted that Met QC Criteria : May 14, 2021
Last Update Posted : May 17, 2021